Amniotic membrane has an innate property which makes it ideal for the management of corneal and conjunctival disorders as well as wound healing and tissue regeneration in eye care.
Using Amniotic membrane therapy in the management of chronic wounds is a revolutionary and exciting new development which provides an alternative option for wounds that fail to heal after using traditional therapies.
With the use of amnion-derived therapy, physicians can now introduce a high concentration of proteins, cytokines, growth factors and essential nutrients to hasten the process of healing.
Numerous studies have investigated using amniotic membrane to reduce scar and adhesion formation and have successfully demonstrated its efficacy and use in spinal and abdominal surgeries to reduce scar formation and adhesions.
Amniotic membrane has no immune response, no associated risk of transplantation and it contains numerous components of the natural cartilage. Studies have concluded that amniotic membrane can successfully assist with cartilage repair.
Nowadays the use of anti bacterial pouch which surrounds the pacemaker device, is becoming common. It has been implicated in reducing the risk of infection considerably. The pouch provides protection for about 10 days and it also helps stabilize the pouch.